Full Text View
Tabular View
No Study Results Posted
Related Studies
Ketoconazole With or Without Alendronate Sodium in Treating Patients With Metastatic Prostate Cancer
This study is ongoing, but not recruiting participants.
Study NCT00019695   Information provided by National Cancer Institute (NCI)
First Received: March 1, 2007   No Changes Posted
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Stage IV Prostate Cancer
Bone Metastases
Adenocarcinoma of the Prostate
Recurrent Prostate Cancer
Additional conditions recognized in this trial
Adenocarcinoma
Bone Marrow Diseases
Bone Neoplasms
Neoplasm Metastasis
Prostatic Neoplasms
More general conditions related to this trial
Bone Diseases
Carcinoma
Genital Diseases, Male
Genital Neoplasms, Male
Hematologic Diseases
Musculoskeletal Diseases
Neoplasms
Neoplasms by Histologic Type
Neoplasms by Site
Neoplasms, Glandular and Epithelial
Neoplastic Processes
Pathologic Processes
Prostatic Diseases
Urogenital Neoplasms
Interventions listed in this trial
alendronate sodium
ketoconazole
Additional drug interventions recognized in this trial
Alendronate
More general drug interventions related to this trial
Anti-Infective Agents
Antifungal Agents
Bone Density Conservation Agents
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
National Cancer Institute (NCI)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services